INCYLARGE

Incyte Corporation

HealthcareBiotechnology
$97.47
$0.00(+0.34%)
52W$57.77
$112.29
Updated May 6, 12:00 AM
RSI53
RS Rating52/99
Beta0.87
Volatility32%
F-Score7/9
Mkt Cap$19.5B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Incyte Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 52), indicating performance broadly in line with the market. Earnings growth of 84% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
52
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.87
vs S&P 500
DEFENSIVE
52W Position
73%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$95.58
50 SMA > 100 SMA$98.76
100 SMA > 150 SMA$97.83
150 SMA > 200 SMA$93.78

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$96.59+0.91%ABOVE
50 SMA$95.58+1.98%ABOVE
100 SMA$98.76-1.31%BELOW
150 SMA$97.83-0.37%BELOW
200 SMA$93.78+3.93%ABOVE

Price Performance

1D+0.3%
1W-0.3%
1M+2.8%
3M-5.1%
6M-7.8%
YTD-3.9%
1Y+56.9%
3Y+13.6%
52-Week Trading Range73% from low
$97.47
52W Low$57.77
52W High$112.29

Technical Indicators

RSI (14)NEUTRAL
52.8
305070
VCP ScoreCOOL
4/10
Base depth: 20.8%

Risk Profile

Beta
0.87
52W Vol
32%
ATR
$3.16
Max DD (1Y)
-18%

Volume Analysis

Today
926.5K
50D Avg
1.47M
Vol Ratio
0.63x
Liquidity
LIQUID

Earnings Momentum

Q2'25+200%
$2.04
Q3'25+291%
$2.11
Q4'25+43%
$1.46
Q1'26+84%
$1.47
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+21.17%
5 Years:+14.03%
3 Years:+14.84%
TTM:+21.48%

Compounded Profit Growth

10 Years:+70.99%
5 Years:
3 Years:+61.56%
TTM:+21.13%

Stock Price CAGR

10 Years:+3.31%
5 Years:+3.70%
3 Years:+13.56%
1 Year:+56.93%

Return on Equity

10Y Avg:10.1%
5Y Avg:16.2%
3Y Avg:14.4%
Last Year:29.3%

Key Metrics

Market Cap$19.5B
Gross Margin91.5%
Net Margin25.0%
Piotroski F-Score7/9

Frequently Asked Questions

Is INCY in an uptrend right now?

INCY has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is INCY overbought or oversold?

INCY's RSI (14) is 53. The stock is in neutral territory, neither overbought nor oversold.

Is INCY outperforming the market?

INCY has a Relative Strength (RS) Rating of 52 out of 99. INCY is performing about average compared to the market.

Where is INCY in its 52-week range?

INCY is trading at $97.47, which is 87% of its 52-week high ($112.29) and 73% above its 52-week low ($57.77).

How volatile is INCY?

INCY has a Beta of 0.87 and 52-week volatility of 32%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.